<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="14321,29987">Glutamate</z:chebi> is an important factor in the mechanisms of neuronal damage following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Blockade of one type of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptor, the <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor, decreases brain <z:mpath ids='MPATH_124'>infarct</z:mpath> size in experimental models of permanent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, but protection in models of transient reversible <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is ambiguous </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the effect of the noncompetitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> dizocipiline (MK-801) on neuronal damage in the CA1 region of the rat hippocampus, using two models of reversible <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>: 10 or 15 min of bilateral common carotid occlusion combined with <z:hpo ids='HP_0002615'>hypotension</z:hpo>, or 6-8.5 min of <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Histopathologic evaluation of neuronal damage was performed 7 days after the ischemic insults </plain></SENT>
<SENT sid="4" pm="."><plain>Thirteen groups of rats (a total of 129 animals) were treated with saline or dizocilpine in single or multiple doses ranging from 0.1 to 5 mg.kg-1, given intravenously or intraperitoneally prior to and/or after the ischemic insult </plain></SENT>
<SENT sid="5" pm="."><plain>In none of the dizocilpine-treated groups could neuronal protection be demonstrated in the CA1 region of the septal as well as dorsotemporal hippocampus, compared to a corresponding saline-treated group </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that systemically administered noncompetitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> do not provide a marked protection against neuronal damage after a transient period of severe forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>